HOME CARE

Expressions of interest: what happens when a buyer is interested in your agency

An expression of interest, often called an indication of interest (IOI), is a short, non-binding message in which a buyer says it wants to explore buying your agency, usually with a preliminary price range and the assumptions behind it. It commits neither side to a deal. A letter of intent (LOI) comes later, after the buyer has seen your data, with a firmer price and binding exclusivity.

What to settle in the letter of intent →How to compare offers side by side →

Akim Guennani

By Akim Guennani, Founder · Updated November 2026

$9.00 to $13.80

Enhabit: the eventual buyer's first non-binding IOI vs. the final cash price per share

36 months

After Medicare enrollment or a majority ownership change, the window in which a home health or hospice provider agreement can't pass to a buyer

What is an expression of interest?

An expression of interest is a buyer's first signal, usually in writing, that it wants to look seriously at acquiring your agency. In home care it typically arrives after the buyer has seen an anonymous summary or had a first call, and before it has seen your claims, payroll or payer contracts. It can be a one-page letter, an email with a price range, or simply a request to learn more.

The names vary and mean roughly the same thing. Bankers running larger sales say indication of interest, or IOI. Others say expression of interest (EOI) or non-binding proposal. What matters is what the message says about price, structure and conditions, not what it is called.

What does a buyer's interest commit either side to?

Almost nothing. Price, structure and timing in an IOI are non-binding, and either side can walk away without owing the other anything. The one thing that does bind is the NDA the buyer signed to see your information, and it keeps applying whether or not the deal goes ahead.

Watch for a buyer that tries to attach obligations at this stage. The common one is exclusivity. In the sale of Enhabit, a public home health and hospice operator, the eventual buyer asked for exclusive talks again and again over 13 months, starting at $9.00 per share. The board never granted it, kept other bidders in the process, and signed at $13.80. The same logic holds for a $3 million agency: exclusivity belongs in an LOI, after you have compared buyers, not in an IOI.

Not binding
The price range, the structure, the timeline, and what the buyer says about your staff and your role.
Binding
The NDA already in place, and any clause the IOI expressly calls binding. Read the last paragraph for these.
Should not be there
Exclusivity, a no-shop promise, or a fee you owe if you sell to someone else.

How is an IOI different from a letter of intent?

An IOI says the buyer would pay something in a range if what you have told it holds up. An LOI names a price and structure and asks you to deal only with that buyer while it confirms them. The LOI comes after the buyer has reviewed your data room and met you. Its price and structure are still mostly non-binding, but its exclusivity, confidentiality and expense clauses usually bind. Our letter of intent guide covers those clauses one by one.

Formal IOIs are mostly a tool of banker-run sales with many bidders, where they are used to narrow the field. In smaller home care deals it is common for a buyer to go from an anonymous summary, an NDA and two or three calls straight to an LOI, especially for a personal care agency with a few million dollars of revenue. That is normal. The questions below still apply to whatever the buyer says about price before the LOI, written or spoken.

What should you do when a buyer expresses interest?

Answer promptly, ask what the price range is based on, and share nothing that identifies your agency until an NDA is signed. Then give every serious buyer the same documents on the same day, so their numbers are comparable and nobody pulls ahead because they saw your payer mix a week earlier.

Keep your own notes on each buyer: which home care segments and states it already operates in, how it plans to pay, and what it said about your caregivers, your office staff and your role after closing. Those notes will matter more than the first number it quotes.

What a sample IOI for a home care agency looks like

A useful IOI answers six questions: how much, based on what, paid how, funded how, subject to what, and how fast. The sample below is written for a fictional Ohio agency with personal care and Medicare home health lines and $500,000 of adjusted EBITDA. The next section takes it apart line by line.

Illustrative sample IOI (hypothetical buyer, agency and figures)

Thank you for sharing your summary under our confidentiality agreement. Based on the information provided, we are interested in acquiring 100 percent of the agency for an enterprise value of $2.0 million to $2.5 million, cash-free and debt-free, with a normal level of working capital, which is 4.0x to 5.0x trailing twelve-month adjusted EBITDA of $500,000 as presented. We expect to pay about 80 percent in cash at closing and the rest as rollover equity or an earnout, funded from our sponsor's current fund and our existing credit facility. We would aim to deliver an LOI within three weeks of data room access and a management meeting, and to close 60 to 120 days after it, subject to our investment committee, diligence and regulatory approvals. This letter is non-binding and creates no obligation for either party except under our existing confidentiality agreement.

What each line of the sample tells you

Read an IOI as a list of assumptions, each of which can move the price later. The table pairs each part of the sample with the question to put back to the buyer.

PartWhat the sample saysWhat to check
Price$2.0 million to $2.5 million enterprise value, cash-free and debt-freeWhether the low end is a number you would accept, after paying off your debt
Basis4.0x to 5.0x of $500,000 adjusted EBITDA "as presented", including your add-backs for owner pay above market and a one-time legal billWhich add-backs the buyer accepted, and which it will test in its quality of earnings review
Working capitalA "normal level" delivered at closingHow it will be measured; slow Medicaid and Medicare Advantage receivables raise the peg
StructureAbout 80 percent cash at closing, 20 percent rollover or earnout, "to be agreed"How the earnout would be measured, and what the rollover equity is worth
FinancingSponsor fund equity plus an existing credit facility, no financing contingencyWhether closing still depends on a lender saying yes
DiligenceQuality of earnings, home health claims and OASIS samples, Review Choice Demonstration results, Medicaid waiver authorizations, caregiver classification and overtime, top referral sourcesAny item that hints at a concern the buyer already has
ApprovalsInvestment committee, state licensure, Ohio Medicaid provider agreements, Medicare change of ownership filingsWhich approvals sit outside your control, and whether the 36-month rule applies
TimelineLOI within three weeks of data room access; closing 60 to 120 days after the LOIWhether it fits your state's licensure and change of ownership timing
Binding termsNone, apart from the existing confidentiality agreementThat there is no exclusivity, no-shop or break fee hidden in the closing paragraph
ContactA named deal leadWhether a decision maker is attached

IOI vs. LOI, side by side

The two documents can look alike on the page. The differences are in timing, precision, and which clauses you can be held to.

Expression or indication of interestLetter of intent
StageAfter an anonymous summary or a first callAfter data room review and meetings with you
PriceA range or multiple, based on your numbers as presentedOne number, or a set multiple of a defined EBITDA, with structure spelled out
Binding partsNone, apart from the NDA already signedUsually exclusivity, confidentiality, expenses and governing law
ExclusivitySometimes requested; don't grant it at this stageUsually included, for a stated period
Diligence before itLittle: a summary, sometimes a callData room, CIM, calls, sometimes a first look at claims or payroll
Typical lengthA short letter or emailA longer letter covering escrow, working capital, earnout terms and your role
If the numbers changeThe range is reset before any LOIThe price is renegotiated, usually after the quality of earnings review

How to read an IOI critically

Start with the width of the range. A buyer that writes $2.0 million to $2.5 million has not yet decided what your agency is worth, which is normal at this stage. With only one buyer at the table, diligence findings usually pull the final price toward the bottom of the range, so judge the letter by its low number, not its high one.

Then find the earnings figure underneath. "As presented" means the buyer used your add-backs without testing them. Its quality of earnings review will test them later, and every dollar of EBITDA it removes comes off the price at the multiple. In home care the usual targets are family members on payroll, owner pay normalization, caregiver overtime, and paid time off that was never accrued.

Next, list the conditions that can move the price later. Home health agencies in Illinois, Ohio, Texas, North Carolina, Florida and Oklahoma are in Medicare's Review Choice Demonstration, so buyers will ask for your affirmation rate; CMS relieves agencies from most reviews once they reach a 90 percent full provisional affirmation rate. Open additional documentation requests, Medicaid recoupments and state survey findings come up in the same way.

Check change of ownership timing. For a Medicare home health agency or hospice, if majority ownership changed within the last 36 months, or the agency enrolled less than 36 months ago, the provider agreement and billing privileges do not convey to the new owner, who must enroll as a new provider and pass a new survey or accreditation. The main exception is two consecutive years of full cost reports. A buyer that has not asked about this has not done many home health deals.

Finally, look at certainty. A buyer paying with equity from a current fund or cash on hand is more likely to close at its number than one that still needs a lender's approval. Ask which home care agencies it has bought in your state: a buyer that already holds a license there knows the licensure steps, the Medicaid waiver programs and the wage rules.

Illustrative example: how a range turns into a lower price

The sample IOI offers 4.0x to 5.0x on $500,000 of adjusted EBITDA as presented, or $2.0 million to $2.5 million. The quality of earnings review rejects a $40,000 add-back for a family member's salary, because the buyer sees a real role it will have to fill, and books $20,000 of unaccrued caregiver paid time off as a cost. Adjusted EBITDA becomes $500,000 minus $60,000, or $440,000. At 4.5x, the midpoint multiple, the price is $1,980,000 rather than the $2,250,000 the midpoint first suggested, a $270,000 drop. If 20 percent is paid as rollover or earnout, cash at closing is $1,584,000, before paying off debt, the working capital true-up and any escrow. Our guide to comparing offers carries this through to what you keep.

What a real home health sale shows about IOIs

Public companies must disclose the history of their sale, which makes them one of the few places you can read IOIs in writing. Enhabit, a home health and hospice operator, described its process in its April 2026 merger proxy. The numbers are per share, not multiples, and your agency is far smaller, but the pattern is the one owners see.

On January 30, 2025, Kinderhook, the eventual buyer, sent a non-binding indication of interest at $9.00 per share with a request for exclusive discussions and an expiry date. Another bidder told Enhabit's bankers in June that it intended to offer about $12.00 and never submitted a formal offer. After CMS released proposed home health payment rates on June 30, 2025 that investors read as a cut, Kinderhook came back at $8.75, again asking for exclusivity, and the board rejected it. After CMS released more favorable final rates on November 28, 2025, indications came in at $12.00, $12.25 and $13.00. In February 2026 Kinderhook offered $13.35 and asked for exclusivity once more; the board refused while another bidder was still in diligence, and the merger agreement signed on February 22, 2026 paid $13.80 in cash per share. Part of the late increases reflected Enhabit's pending lawsuits, which have no counterpart in a small agency sale.

Three lessons carry down to a small agency. Early numbers move with Medicare and Medicaid rate news, in both directions. A stated intention to offer is worth nothing until it is on paper. And exclusivity requested at the IOI stage is a request, not a requirement: Enhabit's board never granted it while other buyers were active, and the price rose.

What to ask the buyer before you send more

Reply to an IOI with questions before documents. Good buyers answer these in a call or a short email, and their answers tell you more than the range.

Owner checklist

  • What earnings figure is the range based on, and which of my add-backs did you accept?
  • What would put you at the low end of the range, and what at the high end?
  • How much is cash at closing, and what would rollover or an earnout look like?
  • Where does the money come from, and whose approval do you still need?
  • Which home care agencies have you bought in this state, and how did their licenses and Medicare or Medicaid enrollment transfer?
  • What happens to my caregivers, my office staff and my role after closing?
  • What do you need from me to reach an LOI, and by when?

What to share once an NDA is signed

A buyer moving toward an LOI usually needs three years of financial statements plus the current year to date, revenue by payer and by referral source, monthly hours or census, caregiver headcount and turnover, licenses and accreditation, Medicare and Medicaid enrollment details including the date of any past ownership change, and any open audits or additional documentation requests. Put them in one data room and give every buyer the same version.

To keep several buyers moving at the same pace, answer questions in writing so everyone gets the same answer, and give one date by which you want each buyer's view of price and structure. You do not need a formal auction for this; you only need to stop one buyer from getting a month ahead of the rest. Have a healthcare M&A attorney read any IOI that asks for exclusivity or contains binding clauses, and every LOI before you sign it.

How buyer interest works with Lartico Capital

With Lartico Capital, a buyer's first step is an introduction you approve, not a priced IOI. You decide which buyers to meet. A buyer signs an NDA before it learns who you are, then reviews the details you choose to share.

From there you talk with buyers directly, and a buyer that wants to go further sends you an LOI. Lartico Capital does not run auctions, does not negotiate for you, and charges you nothing; the buyer pays the fee at closing. The questions in this guide are the ones to ask each buyer you approve.

Sources and methodology

Public transactions provide market context, not a valuation quote for a private practice. Illustrative examples use hypothetical assumptions and are not predictions. This guide is educational and is not legal, tax, accounting, or investment advice.

  1. 1. Enhabit, Inc. definitive merger proxy statement (Schedule 14A), Background of the Merger (U.S. Securities and Exchange Commission (EDGAR)). Dates and per-share amounts of each non-binding indication of interest, expiry dates, exclusivity requests and the board's refusal to grant them, the effect of CMS home health rate releases, and the $13.80 final cash price.
  2. 2. 42 CFR 424.550, Prohibitions on the sale or transfer of billing privileges (Electronic Code of Federal Regulations). The 36-month rule for home health agencies and hospices, the new enrollment and survey requirement, and its exceptions.
  3. 3. Review Choice Demonstration for Home Health Services (Centers for Medicare & Medicaid Services). States in the demonstration and the 90 percent full provisional affirmation rate that qualifies agencies for relief from most reviews.
  4. 4. The Basics of an M&A Letter of Intent (Wyrick Robbins Yates & Ponton LLP). Which LOI terms are typically non-binding and which (exclusivity, confidentiality, expenses, governing law) are typically binding.
  5. 5. Do You Really Need a Letter of Intent? (Bean, Kinney & Korman, P.C.). An IOI comes earlier than an LOI, has fewer deal terms, is styled as a letter from the buyer, and is not always used; it is sometimes requested to narrow the number of buyers.

Reviewed November 2026

Questions owners ask

Straight answers, before you commit to anything.

Is an expression of interest legally binding?+

No. The price, structure and timing in an IOI are non-binding, and either side can walk away. The NDA you signed still binds, and so does any clause the letter expressly calls binding, so read it for those before you reply.

What is the difference between an EOI and an IOI?+

In practice, none. Both describe a buyer's early, non-binding statement that it wants to pursue an acquisition, often with a price range. Different buyers and advisors simply use different names.

How long is an IOI valid?+

Many carry an expiry date a few weeks out. Kinderhook's first indication for Enhabit, sent January 30, 2025, expired March 3. An expiry date is pressure, not a deadline you must meet: Kinderhook's first offer lapsed, and it kept coming back over the next year until it signed at a higher price.

Can the final price come in below the IOI range?+

Yes. It happens when the range rested on add-backs the quality of earnings review rejects, or when Medicare rates or audit findings change the picture. It can also rise when several buyers compete, as it did in Enhabit's sale.

Should I grant exclusivity after an IOI?+

Usually not. Exclusivity belongs in an LOI, once you have compared buyers and agreed on price and structure. Granting it on the strength of a range ends your competition before you know what the deal is.

Should I reply to an IOI if I'm not sure I want to sell?+

Yes. Replying with questions commits you to nothing, and the buyer's answers on price basis, cash at closing and your staff tell you what your agency could fetch. You can stop at any point before you sign a purchase agreement.

Confidential inquiry

Tell us about your agency.

Everything you send stays between us. We never list or shop an agency, and nothing goes to a buyer without your explicit approval. There is no cost to you at any stage.